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Background
Various studies have hypothesized a common inflamma-
tory pathogenesis for headache and hypovitaminosis D
(HD), showing that migraine patients have low levels of
vitamin D [1]. Other studies did not confirm this [2].
Recently, a relationship between HD and reduced pharma-
cological response has been hypothesized, while vitamin D
supplementary intake in HD patients may contribute to
clinical improvement [3]. Aim of our prospective study
was to evaluate the relationship between vitamin D levels
and headache frequency and management in a cohort of
patients accessing to our Centre for Headache from April
2015 to October 2015. We present preliminary data about
patients enrolled until June 2015.
Materials and methods
We enrolled 22 patients (6 males, 16 females; 45.41±11.22
mean age) accessing our Center from April 2015 to June
2015. We assigned patients to one of two groups accord-
ing to headache frequency: Group A patients had a clinical
history of episodic migraine (EM; n=7; < 8 headache days/
month); Group B patients had a clinical history of chronic
migraine and/or medication-overuse headache (CH/MOH;
n=15; > 8 headache days/month). We excluded < 18 and >
55 year old patients and patients already supplementing
vitamin D. At access, all patients received neurological and
headache assessment, pharmacological evaluation, disabil-
ity assessment and psychological evaluation. We took
blood samples to obtain the dosage of vitamin D (normal
values = 30-100 ng/ml). Using SOFA Statistics 1.4.4 soft-
ware, we calculated descriptive indicators and Pearson’s
correlation coefficient (r) between headache frequency and
vitamin D levels. We compared groups on vitamin D levels
using independent samples Student’s t-test. We set p <
0.05 as threshold of statistical significance. The local ethi-
cal committee approved the study design. All patients
signed an informed consent to the research.
Results
Vitamin D levels (M±DS) in all patients (n=22) fell
below the normal range (13.05±5.70). Vitamin D levels
were lower (M±DS) among Group A (CM+MOH)
patients (11.73±5.98) than Group B (EM) patients (15.86
±4.10); Student’s t-test showed no statistically significant
difference between groups on vitamin D levels (t = 1.642;
p = 0.116). While Pearson’s test did not show correla-
tion between vitamin D levels and headache frequency
(r = -0.308; p = 0.163), scatterplot suggests that such
hypothetical inverse relationship, given a sample expan-
sion, should be investigated (fig. 1).
Conclusions
Migraine patients appear to have a high rate of hypovita-
minosis D. Since vitamin D may coadiuvate the absorption
of medication, further studies should investigate HD role
in reducing migraine pharmacological management
efficacy.
Written informed consent to publish was obtained
from the patient(s).
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Figure 1 Scatter plot between headache frequency and vitamin D
levels.
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